PMID: 9551737Apr 29, 1998Paper

Clinical effect of Diskus dry-powder inhaler at low and high inspiratory flow-rates in asthmatic children

The European Respiratory Journal
K G NielsenH Bisgaard

Abstract

In vitro studies with the Diskus inhaler at low and high flow rates show consistent doses of drug as fine particles <4.7 microm. The present study was designed to ascertain whether this in vitro flow independency translates into flow-independent clinical effect when the device is used by patients at low (30 L x min[-1]) and high (90 L x min[-1]) flow rates. A pilot study in 129 children aged 3-10 yrs demonstrated that 99% of children of 3 yrs and above can generate a flow > or = 30 L x min(-1) through the device, while 26% performed > or = 90 L x min(-1). Eighteen children aged 8-15 yrs with exercise induced asthma inhaled placebo or salmeterol 50 microg at either 30 L x min(-1) or 90 L x min(-1). Exercise challenges were carried out 1 h and 12 h after dosing. The maximum percentage fall in forced expiratory volume in one second (FEVI) after exercise 12 h after treatment was significantly less after salmeterol at either flow rates as compared to placebo. There was no significant difference in the protection from salmeterol on the day of low-flow inhalation versus the day of high-flow inhalation. Consistent in vitro fine particle dosing from the Diskus inhaler translates into a consistent clinical effect at low and high flow rat...Continue Reading

Citations

Nov 9, 2004·Pediatric Pulmonology·Edward J O'Connell
Jan 29, 2003·International Journal of Pharmaceutics·Marielle E A C BroedersHons Th M Folgering
Nov 6, 2001·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·L Borgström
Jun 26, 2003·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·Mariëlle E A C BroedersHans T M Folgering
Jan 2, 2007·Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine·H A TiddensT A Standaert
Jun 6, 2014·PloS One·Anne J LexmondAnne H de Boer
Sep 6, 2003·Paediatric Drugs·Fernando Maria De Benedictis, David Selvaggio
Aug 3, 2013·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Huaidong LiHui Zhang
Nov 22, 2005·Expert Opinion on Drug Delivery·William E Berger
Feb 24, 2006·Pediatrics International : Official Journal of the Japan Pediatric Society·Yoko S AdachiToshio Miyawaki
Feb 26, 2000·Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners·L A Hannemann
Sep 12, 2015·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Francesca ButtiniIrene Pasquali
May 13, 2014·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Wahida AzouzHenry Chrystyn
Nov 4, 2016·Pharmaceutical Research·Francesca ButtiniPaolo Colombo
Apr 17, 2014·Advanced Drug Delivery Reviews·M HoppentochtA H de Boer
Oct 16, 2016·Pharmaceutical Research·Jeffry Weers, Andy Clark
Jul 17, 2007·Respiratory Medicine·Raid A M Al-ShowairHenry Chrystyn
Sep 1, 2016·Respiratory Medicine·Peter HaidlRolf Michael Cloes
Nov 11, 2017·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Conor A RuzyckiWarren H Finlay
Mar 20, 2004·Pediatric Pulmonology. Supplement·Harm Tiddens
Aug 31, 2004·Pediatric Pulmonology·Lea BenturIsrael Amirav
Apr 19, 2002·Paediatric Drugs·John Massie
May 20, 2020·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Jussi HaikarainenLeo Pekka Malmberg
Mar 27, 1999·Pediatric Pulmonology. Supplement·M Dolovich
Jun 11, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Wiparat ManuyakornWanlapa Teawsomboonkit
Feb 18, 2012·Primary Care Respiratory Journal : Journal of the General Practice Airways Group·Wahida Azouz, Henry Chrystyn
Feb 1, 2021·International Journal of Pharmaceutics·Hideo NakadaMayumi Mochizuki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.